![Chris Picardo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Picardo
Director/Miembro de la Junta en Modulus Therapeutics, Inc. .
Cargos activos de Chris Picardo
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Modulus Therapeutics, Inc.
![]() Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020. | Director/Miembro de la Junta | - | - |
Life Science Washington | Director/Miembro de la Junta | 11/01/2022 | - |
Historial de carrera de Chris Picardo
Formación de Chris Picardo.
Williams College | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Modulus Therapeutics, Inc.
![]() Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020. | Commercial Services |
Life Science Washington |
- Bolsa de valores
- Insiders
- Chris Picardo
- Experiencia